DaVita (BSP:DVAI34) Gross-Profit-to-Asset % : 23.73% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is DaVita Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. DaVita's annualized Gross Profit for the quarter that ended in Dec. 2023 was R$19,744 Mil. DaVita's average Total Assets over the quarter that ended in Dec. 2023 was R$83,191 Mil. Therefore, DaVita's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 23.73%.

DaVita Gross-Profit-to-Asset % Historical Data

The historical data trend for DaVita's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Gross-Profit-to-Asset % Chart

DaVita Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

19.63

23.13

22.39

19.22

21.82

DaVita Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															19.55	19.29	21.64	25.10	23.73

Competitive Comparison of DaVita's Gross-Profit-to-Asset %

For the Medical Care Facilities subindustry, DaVita's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaVita's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where DaVita's Gross-Profit-to-Asset % falls into.

DaVita Gross-Profit-to-Asset % Calculation

DaVita's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	18719.343	/	( (88795.453	+	82775.153)	/ 2 )
	=	18719.343	/	85785.303
	=	21.82 %

DaVita's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	19743.804	/	( (83605.968	+	82775.153)	/ 2 )
	=	19743.804	/	83190.5605
	=	23.73 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

DaVita Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of DaVita's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita (BSP:DVAI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

DVA:USA TRL:Germany

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines